COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA (2016) Kratz A, Sahm F, Schrimpf D, Jones DT, Reuss D, Koelsche C, Huang K, et al. Conference contribution Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain (2016) Goerig N, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt M, Dörfler A, et al. Journal article Comparison of 68 Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results (2015) Afshar-Oromieh A, Wolf MB, Kratochwil C, Giesel FL, Combs SE, Dimitrakopoulou-Strauss A, Gnirs R, et al. Journal article Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors (2014) Kratochwil C, Combs SE, Leotta K, Afshar-Oromieh A, Rieken S, Debus J, Haberkorn U, Giesel FL Journal article Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth (2014) Stache C, Hölsken A, Fahlbusch R, Flitsch J, Schlaffer SM, Buchfelder M, Buslei R Journal article End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: A questionnaire-based survey (2013) Heese O, Vogeler E, Martens T, Schnell O, Tonn JC, Simon M, Schramm J, et al. Journal article Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (2013) Wick W, Steinbach JP, Platten M, Hartmann C, Wenz F, Von Deimling A, Shei P, et al. Journal article Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography (2009) Schnell O, Krebs B, Carlsen J, Miederer I, Goetz C, Goldbrunner RH, Wester HJ, et al. Journal article